Počet záznamov: 1
neuritída autoimunitná experimentálna
SYS d009444 LBL 00000cx--j22000003--45-- 005 20240119195832.3 100 $a 19920223csloy0103----ba0 152 $b mesh 250 $a neuritída autoimunitná experimentálna $x BL $x CF $x CI $x CL $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $8 slo 300 1-
$a 2005 (1982) $8 eng 300 1-
$a Myelin Sheath (1966-1981) $8 eng 300 1-
$a Neuritis (1966-1981) $8 eng 300 1-
$a Peripheral Nerves (1966-1981) $8 eng 330 1-
$a An experimental animal model for the demyelinating disease of GUILLAINE-BARRE SYNDROME. In the most frequently used protocol, animals are injected with a peripheral nerve tissue protein homogenate. After approximately 2 weeks the animals develop a neuropathy secondary to a T cell-mediated autoimmune response directed towards the MYELIN P2 PROTEIN in peripheral nerves. Pathologic findings include a perivascular accumulation of macrophages and T lymphocytes in the peripheral nervous system, similar to that seen in the Guillaine-Barre syndrome. (From Adams et al., Principles of Neurology, 6th ed, p1314; J Neuroimmunol 1998 Apr 1;84(1):40-52) $8 eng 450 $a Allergic Neuritis, Experimental $5 e $8 eng 450 $a Autoimmune Neuritis, Experimental $5 e $8 eng 450 $a Neuritis, Experimental Allergic $5 e $8 eng 450 $a neuritída experimentálna alergická $5 e $8 slo 450 $a neuritída experimentálna autoimunitná $5 e $8 slo 686 $a C10.114.703.700 686 $a C10.668.829.650.500 686 $a C20.111.258.625.700 686 $a E05.598.500.500.875 750 $a Neuritis, Autoimmune, Experimental $8 eng 801 -0
$a US $b DNLM $c 19920223 801 -2
$a SK $b BA006 $c 20050304 820 $a coordinate with GUILLAINE-BARRE SYNDROME if pertinent $8 eng 980 $x M
Počet záznamov: 1